Similar articles

• Lidocaine alleviates cytotoxicity-resistance in lung cancer A549/DDP cells via down-regulation of miR-21.

  Yang Q, Zhang Z, Xu H, Ma C. Yang Q, et al. Mol Cell Biochem. 2019 Jun;456(1-2):63-72. doi: 10.1007/s11010-018-3490-x. Epub 2019 Jan 14. Mol Cell Biochem. 2019. Retraction in: Mol Cell Biochem. 2024 Mar;479(3):737. doi: 10.1007/s11010-024-04971-9. PMID: 30644017 Retracted.
• Lidocaine alleviates cisplatin resistance and inhibits migration of MGC-803/DDP cells through decreasing miR-10b.

  Zhang X, Gu G, Li X, Zhang C. Zhang X, et al. Cell Cycle. 2020 Oct;19(19):2530-2537. doi: 10.1080/15384101.2020.1809914. Epub 2020 Sep 5. Cell Cycle. 2020. PMID: 32892697 Free PMC article.
• Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.

  Qin X, Yu S, Zhou L, Shi M, Hu Y, Xu X, Shen B, Liu S, Yan D, Feng J. Qin X, et al. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017. Int J Nanomedicine. 2017. PMID: 28553110 Free PMC article.
• Downregulation of PEBP4, a target of miR-34a, sensitizes drug-resistant lung cancer cells.

  Yu G, Zhong N, Chen G, Huang B, Wu S. Yu G, et al. Tumour Biol. 2014 Oct;35(10):10341-9. doi: 10.1007/s13277-014-2284-3. Epub 2014 Jul 21. Tumour Biol. 2014. PMID: 25038915
• [The effect and mechanism of microRNA-21 on cis-dichlorodiamineplatinum resistance in lung cancer cell strain].

  Ren L, Huang C, Liu YH, Yu Y, Lin L, Wen LJ. Ren L, et al. Zhonghua Yi Xue Za Zhi. 2016 May 17;96(18):1454-8. doi: 10.3760/cma.j.issn.0376-2491.2016.18.014. Zhonghua Yi Xue Za Zhi. 2016. PMID: 27266356 Chinese.